First transcatheter aortic valve replacement with gadobutrol in a patient with severe contrast allergy

Vinayak Nagaraja, Rajiv Gulati, Mohamad Adnan Alkhouli, Mackram F. Eleid, Eric E. Williamson, Charanjit S. Rihal

Research output: Contribution to journalArticlepeer-review

Abstract

Iodinated contrast media (ICM) is an integral part of interventional cardiology procedures however, a proportion of patients have contrast allergy. We report the first TAVR performed with a gadolinium-based contrast agent, gadobutrol (GBCA) in a patient with severe recurrent ICM allergic reactions despite prophylactic treatment.

Original languageEnglish (US)
JournalCardiovascular Revascularization Medicine
DOIs
StateAccepted/In press - 2022

Keywords

  • Contrast allergy
  • Severe aortic stenosis
  • Transcatheter aortic valve replacement

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'First transcatheter aortic valve replacement with gadobutrol in a patient with severe contrast allergy'. Together they form a unique fingerprint.

Cite this